Lead discovery of quinoxalinediones as an inhibitor of dipeptidyl peptidase-IV (DPP-IV) by high-throughput screening

  • Hyae Gyeong Cheon
  • , Chul Min Lee
  • , Beom Tae Kim
  • , Ki Jun Hwang*
  • *Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

Abstract

N-Ureido-quinoxalinedione derivatives have been discovered as leads for a novel series of dipeptidyl peptidase-IV (DPP-IV) inhibitors through high-throughput screening of our chemical library. A brief structure-activity relationship of the compounds was investigated. Among them, entry 5 showed the most potent inhibitory activity. The nitro group in quinoxaline moiety and the aromatic sulfonyl substituted ureido functional group seem to be important to increase the potency dramatically.

Original languageEnglish
Pages (from-to)2661-2664
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume14
Issue number10
DOIs
StatePublished - 2004.05.17

Quacquarelli Symonds(QS) Subject Topics

  • Medicine
  • Engineering - Petroleum
  • Pharmacy & Pharmacology
  • Chemistry
  • Biological Sciences

Fingerprint

Dive into the research topics of 'Lead discovery of quinoxalinediones as an inhibitor of dipeptidyl peptidase-IV (DPP-IV) by high-throughput screening'. Together they form a unique fingerprint.

Cite this